Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years — Stella

Home/Influenza/

View on ClinicalTrials.gov

Recruiting

Back to Influenza trials

Trial locations(1 site)

United States

Kaiser Permanente Northern California (entire region), Oakland, California

Key details

Sponsor

Kaiser Permanente

Collaborators

Seqirus

Enrollment target

~960,000 participants

Started

August 2023

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

65 Years and older

Last updated September 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.